Comparative study of the effect of 4-week treatment with ossein-hydroxyapatite compound versus calcium carbonate on bone biomarkers in young women with low calcium intake. Prospective, monocenter, randomized, open-label, two-period,cross-over trial
Comparative study of the effect of 4-week treatment with ossein-hydroxyapatite compound versus calcium carbonate on bone biomarkers in young women with low calcium intake. Prospective, monocenter, randomized, open-label, two-period,cross-over trial
Comparative study of the effect of 4-week treatment with ossein-hydroxyapatite compound versus calcium carbonate on bone biomarkers in young women with low calcium intake. Prospective, monocenter, randomized, open-label, two-period,cross-over trial
Statut
Status :
Terminé
Type d'étude
Phase IV
Age Min.
18
Ans
Age Max.
64
Ans
Genre
Femme
Aire thérapeutique :
Rhumatologie
Maladie :
Sujets sains
Traitement :
L0006
Phase :
Phase IV
Date de début de l'étude :
09 Septembre 2008
End date :
13 Janvier 2009
Identifiant de l'essai :
L00006 CP 403 3A
Identifiant EudraCT/CTIS :
2008-002280-14
Envoyer par email